$15.470
-0.079 (-0.51%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de SMMT por análisis de gráficos similares
Alphio's SMMT stock price prediction model matches the current Summit Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.04 (-2.78%). The 1-week path is $15.05 (-2.74%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Summit Therapeutics Inc?
Summit Therapeutics Inc is a good buy right now due to its recent $2 billion investment from AstraZeneca, which provides a significant funding boost and a target price of $18.36 per share, representing a 19% premium over the current price of $15.47. Additionally, the forward P/E ratio of 3.72 indicates potential for growth compared to its current valuation. The main risk is the company's ongoing negative earnings, with an EPS estimate of -0.28 for the next quarter, which could impact investor sentiment if results do not meet expectations.
SMMT cerró en $15.47 el Friday, tras bajar -0.51%
Summit Therapeutics Inc (SMMT) last closed at $15.47, losing -0.51%. These facts feed the 1-day and 1-week SMMT price prediction above.
Consenso de analistas
Summit Therapeutics Inc (SMMT): 6 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Summit Therapeutics Inc (SMMT) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de SMMT, ordenadas por similitud.
Análisis de estacionalidad de SMMT
Historically the probability of a positive October return for SMMT is 76.19%. April offers the highest probability of a positive month at 93.75%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de SMMT
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $24.01 | $28.54 | $28.55 | +84.46% |
| Nov 2026 | $30.71 | $31.00 | $33.94 | +100.40% |
| Dec 2026 | $23.40 | $28.61 | $32.18 | +84.94% |
En 2026, se proyecta que Summit Therapeutics Inc (SMMT) oscile entre $23.40 y $33.94.
Previsión mensual de Summit Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Summit Therapeutics Inc promedie $28.54, con un mínimo de $24.01 y un máximo de $28.55.
En Nov de 2026, se proyecta que Summit Therapeutics Inc promedie $31.00, con un mínimo de $30.71 y un máximo de $33.94.
En Dec de 2026, se proyecta que Summit Therapeutics Inc promedie $28.61, con un mínimo de $23.40 y un máximo de $32.18.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.